financetom
Business
financetom
/
Business
/
Market Chatter: Apple Challenges UK Order for 'Back Door' in Encryption
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Market Chatter: Apple Challenges UK Order for 'Back Door' in Encryption
Mar 4, 2025 10:59 AM

01:37 PM EST, 03/04/2025 (MT Newswires) -- Apple ( AAPL ) has filed a legal complaint in the UK to challenge a government demand for a "back door" into its encrypted iCloud service, the Financial Times reported Tuesday, citing sources with knowledge of the matter.

The dispute reportedly revolves around a "technical capability notice" Apple ( AAPL ) received under the Investigatory Powers Act, which gives authorities the power to require companies to break encryption.

Apple ( AAPL ) argues that this order threatens its most secure cloud protection feature, Advanced Data Protection, which led the company to withdraw this service in the UK rather than comply, the media outlet reported.

The Investigatory Powers Tribunal, an independent body overseeing security service complaints, will decide if the government's directive was lawful, according to the Financial Times.

The hearing could reportedly take place soon, though it is unclear if proceedings will be made public due to possible national security concerns.

Apple ( AAPL ) and the UK's Home Office did not immediately respond to requests for a comment by MT Newswires.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 236.62, Change: -1.41, Percent Change: -0.59

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
--Element Solutions Keeps Quarterly Dividend at $0.08 Per Share; Payable Dec. 16 to Shareholders of Record on Dec. 2
--Element Solutions Keeps Quarterly Dividend at $0.08 Per Share; Payable Dec. 16 to Shareholders of Record on Dec. 2
Nov 19, 2024
05:48 PM EST, 11/18/2024 (MT Newswires) -- Price: 26.80, Change: -0.17, Percent Change: -0.63 ...
Flushing Financial Files $400 Million Mixed-Shelf Offering
Flushing Financial Files $400 Million Mixed-Shelf Offering
Nov 19, 2024
05:55 PM EST, 11/18/2024 (MT Newswires) -- Flushing Financial ( FFIC ) filed a registration statement with the US Securities and Exchange Commission Monday for the potential sale of up to $400 million of its securities from time to time in one or more offerings. The filing covers debt securities, preferred stock, depository shares, common stock, warrants, and units. ...
Ecarx, Geely Agree to 3-Year R&D, Components Deal
Ecarx, Geely Agree to 3-Year R&D, Components Deal
Nov 19, 2024
05:49 PM EST, 11/18/2024 (MT Newswires) -- Ecarx ( ECX ) said Monday it agreed to a components procurement, and research and development services deal with Geely Automobile, Zhejiang HUANFU and Hangzhou Langge. Under the agreement, Geely will purchase automobile components and R&D services from Ecarx ( ECX ), Zhejiang HUANFU and Hangzhou Langge, for three years ending Dec. 31,...
Rocket Pharmaceuticals to Resume Patient Enrollment in RP-L301 Gene Therapy Phase 2 Trial in 2025
Rocket Pharmaceuticals to Resume Patient Enrollment in RP-L301 Gene Therapy Phase 2 Trial in 2025
Nov 19, 2024
05:47 PM EST, 11/18/2024 (MT Newswires) -- Rocket Pharmaceuticals ( RCKT ) said Monday that, while the Phase 2 trial for its experimental RP-L301 gene therapy is ready for patient enrollment, it will not begin until next year as the company is currently directing resources toward other programs. RP-L301 is being studied for the treatment of Pyruvate Kinase Deficiency, a...
Copyright 2023-2026 - www.financetom.com All Rights Reserved